⌘K
t
Christopher Samler, Executive Chair of Induction Healthcare Group PLC, purchased 266,667 ordinary shares in the Company at 22.5 pence per share on 13 January 2023. Following this transaction, Mr. Samler holds 266,667 ordinary shares, representing 0.29 per cent. of Induction Healthcare Group PLC's current issued share capital.
| Date | 16 Jan 2023 |
| Time | 12:20:07 |
| Category | Director/PDMR dealings |
| ID | 8596M |
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Purchase of shares by Executive Chair
Induction (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, announces that Christopher Samler, Executive Chair purchased 266,667 ordinary shares in the Company at 22.5 pence on 13 January 2023.
As a result, Mr Samler holds 266,667 ordinary shares, representing 0.29 per cent. of the Company's current issued share capital.
ENQUIRIES
|
Induction Christopher Samler, Executive Chair Paul Tambeau, Chief Operating Officer
|
Via Walbrook PR Ltd: [email protected]
|
|
|
|
|
Singer Capital Markets (Nominated Adviser and Broker) |
+44 (0)20 7496 3000 |
|
Philip Davies |
|
|
|
|
|
Walbrook PR Ltd |
+44 (0)20 7933 8780 or [email protected] |
|
Paul McManus / Kiki Zaccagnini |
Mob: +44 (0)7980 541 893 / +44 (0) 07387 744 286 |
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
a. |
Name |
Christopher Samler |
|
2. |
Reason for the notification |
|
|
a. |
Position/status |
Executive Chair |
|
a. |
Initial notification /Amendment |
Initial notification |
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a. |
Name |
Induction Healthcare Group plc |
|
b. |
LEI |
213800RY96GCZQW5TP19 |
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a. |
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 0.5 pence each
GB00BJ0M3545 |
|
b. |
Nature of the transaction |
Purchase of Ordinary Shares |
|
c. |
Price(s) and volume(s) |
22.5 pence 266,667 Ordinary Shares |
|
d. |
Aggregated information Aggregated volume Price |
N/A |
|
e. |
Date of the transaction |
13 January 2023 |
|
f. |
Place of the transaction |
Off market transaction |